These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6318337)

  • 1. [Pharmacokinetic profile of a slow-release ketoprofen preparation].
    Flouvat B; Stheneur A; Massias P
    Sem Hop; 1983 Dec; 59(46):3187-90. PubMed ID: 6318337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pharmacokinetic study of repeated doses of a new controlled release form of ketoprofen.
    Houghton GW; Dennis MJ; Templeton R; Calvert RM; Cresswell DG
    Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):131-3. PubMed ID: 6715081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability study on a new slow-release formulation of ketoprofen.
    Caruso I; Frigerio E; Fumagalli M; Liverta C; Moro L; Tamassia V
    J Int Med Res; 1982; 10(4):229-33. PubMed ID: 7117681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of a slow-release preparation of ketoprofen lysine in man.
    Borsa M; Tonon GC; Ronchi C; Zanolo G; Canali S
    Arzneimittelforschung; 1983; 33(10):1497-500. PubMed ID: 6418181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and in vitro evaluation of slow release ketoprofen microcapsules formulated into tablets and capsules.
    el Khodairy KA; Eshra AG; Nada AH; Mortada SA
    J Microencapsul; 1992; 9(3):365-73. PubMed ID: 1403487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suprofen sustained release kinetics in healthy male volunteers. 1st communication: a single dose open crossover bioavailability study of suprofen sustained release tablets versus capsules.
    Michos N; Zulliger HW; Barkworth MF; Johnson KJ; Rehm KD; Töberich H; Klein G
    Arzneimittelforschung; 1986 Jun; 36(6):941-8. PubMed ID: 3741528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative pharmacokinetics of ketoprofen derived from single oral doses of ketoprofen capsules or a novel sustained-release pellet formulation.
    Houghton GW; Dennis MJ; Rigler ED; Parsons RL
    Biopharm Drug Dispos; 1984; 5(3):203-9. PubMed ID: 6487749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind, interpatient comparison of plain and slow-release ketoprofen in osteoarthritis.
    Marcolongo R; Rubegni M; Provvedi D; Giordano N; Frati E; Bruni G
    Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):377-81. PubMed ID: 6381334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The pharmacokinetics and bioequivalence of acipimox sustained-release tablets after a single and multiple oral administration in healthy dogs].
    Yang XG; Nie SF; Bai HJ; Zhang GJ; Pan WS
    Yao Xue Xue Bao; 2005 May; 40(5):457-61. PubMed ID: 16220793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetics of ketoprofen in the synovial fluid].
    Kennedy AC
    Sem Hop; 1983 Dec; 59(46):3208-9. PubMed ID: 6318342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary pharmacokinetics of orally administered ketoprofen in man.
    Houghton GW; Dennis MJ; Rigler ED; Parsons RL
    Eur J Drug Metab Pharmacokinet; 1984; 9(3):201-4. PubMed ID: 6519121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of ketoprofen bioavailability by formation of microsponge tablets.
    Comoglu T; Savaşer A; Ozkan Y; Gönül N; Baykara T
    Pharmazie; 2007 Jan; 62(1):51-4. PubMed ID: 17294814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Double-blind comparative study of Bi-Profenid tablets and Profenid capsules in inflammatory rheumatism].
    Camus JP; Fournie A; Ayrolles C; Koeger AC; Prier A
    Sem Hop; 1983 Dec; 59(46):3221-4. PubMed ID: 6318346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steady-state bioavailability of two sustained-release quinidine preparations: quinidine gluconate versus quinidine sulfate.
    Taggart WV; Holyoak W
    Clin Ther; 1983; 5(4):357-64. PubMed ID: 6871920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and in vitro/in vivo evaluation of a ketoprofen orally disintegrating/sustained release tablet.
    Wei Q; Yang F; Luan L
    Drug Dev Ind Pharm; 2013 Jun; 39(6):928-34. PubMed ID: 22401710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic profile of controlled release ketoprofen in elderly patients.
    Dennis MJ; French PC; Crome P; Babiker M; Shillingford J; Hopkins R
    Br J Clin Pharmacol; 1985 Dec; 20(6):567-73. PubMed ID: 4091989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Open clinical trial of a new oral galenic form of ketoprofen].
    Huck F; Lecocq J; Meyer R; Kuntz JL; Asch L
    Sem Hop; 1983 Dec; 59(46):3240-2. PubMed ID: 6318350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of meal size and composition on the bioavailability of ketoprofen (Oruvail).
    Nievel JG; Havard CW; Mitchell P; Gudgeon A; Kaye CM
    Xenobiotica; 1987 Apr; 17(4):487-92. PubMed ID: 3604255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic characteristics of a new multiple unit sustained release formulation of sodium valproate.
    Wangemann M; Retzow A; Vens-Cappell B
    Int J Clin Pharmacol Ther; 1999 Feb; 37(2):100-8. PubMed ID: 10082174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronokinetics of ketoprofen administered orally and by continuous venous infusion].
    Queneau P; Decousus H; Ollagnier M; Cherrah Y; Perpoint B; Hocquart J
    Rev Rhum Mal Osteoartic; 1985 Jun; 52(6):403-8. PubMed ID: 4048810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.